Publications
2024
Garcia-Morena,
D., Fernandez-Cantos, M. V., Escalera, S. L.,
Lok, J., Iannone, V., Cancellieri, P., Maathuis, W., Panagiotou,
G., Aranzamendi, C., Aidy, S. E.,
Kolehmainen, M., El-Nezami, H., Wellejus, A., & Kuipers,
O. P. (2024). In Vitro Influence of Specific
Bacteroidales Strains on Gut and Liver Health Related to Metabolic
Dysfunction-Associated Fatty Liver Disease.
Probiotics and Antimicrobial Proteins.
Advance online publication. https://doi.org/10.1007/s12602-024-10219-1
2023
Scheurink,
T. A. W., Borkent, J., Gangadin, S.
S., El Aidy, S., Mandl, R., & Sommer,
I. E. C. (2023). Association between gut permeability,
brain volume, and cognition in healthy participants and patients
with schizophrenia spectrum disorder. Brain and
Behavior, 13(6), Article e3011. https://doi.org/10.1002/brb3.3011
Jansma,
J., Thome, N. U., Schwalbe, M., Chatziioannou,
A. C., Elsayed, S. S., van Wezel, G. P., van den Abbeele, P., van
Hemert, S., & El Aidy, S. (2023). Dynamic
effects of probiotic formula ecologic®825 on human small
intestinal ileostoma microbiota: A network theory approach.
Gut Microbes, 15(1), Article
2232506. https://doi.org/10.1080/19490976.2023.2232506
Mahdy,
M. S., Azmy, A. F., Dishisha, T., Mohamed, W. R., Ahmed, K. A.,
Hassan, A., Aidy, S. E., & El-Gendy, A. O. (2023).
Irinotecan-gut microbiota interactions and the capability of
probiotics to mitigate Irinotecan-associated toxicity.
BMC Microbiology, 23(1), Article 53.
https://doi.org/10.1186/s12866-023-02791-3
Jansma,
J., Chatziioannou, A. C., Castricum, K., van Hemert,
S., & El Aidy, S. (2023). Metabolic network
construction reveals probiotic-specific alterations in the
metabolic activity of a synthetic small intestinal
community. Msystems, 8(5),
Article 00332-23. https://doi.org/10.1128/msystems.00332-23
Waclawiková,
B., Cesar Telles de Souza, P., Schwalbe,
M., Neochoritis, C. G., Hoornenborg, W.,
Nelemans, S. A., Marrink, S. J., & El Aidy,
S. (2023). Potential binding modes of the gut
bacterial metabolite, 5-hydroxyindole, to the intestinal L-type
calcium channels and its impact on the microbiota in rats.
Gut Microbes, 15(1), Article
2154544. https://doi.org/10.1080/19490976.2022.2154544
2022
Bunt,
D. V., Aidy, S. E., & Minnaard, A.
J. (2023). Divergent Total Synthesis of Fornicin A,
Fornicin D, and Ganodercin D, Meroterpenoids from Ganoderma
Mushrooms. European Journal of Organic
Chemistry, 26(6), Article e202201446. https://doi.org/10.1002/ejoc.202201446
El
Aidy, S., & Waclawiková, B. (2022).
5-hydroxyindole and analogs thereof as
stimulants of gut motility. (Patent No.
WO2022010352).
González-Dávila,
P., Schwalbe, M., Danewalia, A., Dalile, B.,
Verbeke, K., Mahata, S. K., & El Aidy, S. (2022).
Catestatin selects for colonization of
antimicrobial-resistant gut bacterial communities.
The ISME journal, 16,
1873–1882. https://doi.org/10.1038/s41396-022-01240-9
Krieg,
C., Weber, L. M., Fosso, B., Marzano, M., Hardiman, G., Olcina, M.
M., Domingo, E., El Aidy, S., Mallah, K., Robinson, M.
D., & Guglietta, S. (2022). Complement downregulation
promotes an inflammatory signature that renders colorectal cancer
susceptible to immunotherapy. Journal for
immunotherapy of cancer, 10(9), Article
e004717. https://doi.org/10.1136/jitc-2022-004717
Waclawiková,
B., Codutti, A., Alim, K., & El Aidy, S.
(2022). Gut microbiota-motility interregulation: Insights
from in vivo, ex vivo and in silico studies. Gut
Microbes, 14(1), Article 1997296. https://doi.org/10.1080/19490976.2021.1997296
González-Dávila,
P., Schwalbe, M., Danewalia, A.,
Wardenaar, R., Dalile, B., Verbeke, K., Mahata, S. K.,
& El Aidy, S. (2022). Gut microbiota
transplantation drives the adoptive transfer of colonic
genotype-phenotype characteristics between mice lacking catestatin
and their wild type counterparts. Gut
Microbes, 14(1), Article e2081476. https://doi.org/10.1080/19490976.2022.2081476
Jansma,
J., van Essen, R., Haarman, B. C. M.,
Chatziioannou, A. C., Borkent, J., Ioannou,
M., van Hemert, S., Sommer, I. E. C.,
& El Aidy, S. (2022). Metabolic phenotyping
reveals a potential link between elevated faecal amino acids, diet
and symptom severity in individuals with severe mental
illness. Journal of Psychiatric
Research, 151, 507-515. https://doi.org/10.1016/j.jpsychires.2022.05.011
Maassen,
S., Warner, H., Ioannidis,
M., Jansma, J., Markus, H., El Aidy,
S., Chiara, M.-D., Chiara, J. L., Maierhofer, L., Weavers,
H., & van den Bogaart, G. (2022).
Mitochondrial interaction of fibrosis-protective 5-methoxy
tryptophan enhances collagen uptake by macrophages.
Free Radical Biology and Medicine,
188, 287-297. Article 202206235. https://doi.org/10.1016/j.freeradbiomed.2022.06.235
van
Kessel, S. P., Bullock, A., van Dijk, G.,
& El Aidy, S. (2022). Parkinson's disease
medication alters small intestinal motility and microbiota
composition in healthy rats. Msystems,
7(1), Article e0119121. https://doi.org/10.1128/msystems.01191-21
2021
Muntjewerff,
E. M., Tang, K., Lutter, L., Christoffersson, G., Nicolasen, M. J.
T., Gao, H., Katkar, G. D., Das, S., Ter Beest, M., Ying, W.,
Ghosh, P., Aidy, S. E., Oldenburg, B., van den
Bogaart, G., & Mahata, S. K. (2021). Chromogranin
A regulates gut permeability via the antagonistic actions of its
proteolytic peptides. Acta
physiologica, 232(2), Article e13655. https://doi.org/10.1111/apha.13655
Waclawiková,
B., Bullock, A., Schwalbe, M.,
Aranzamendi, C., Nelemans, S. A., van Dijk,
G., & El Aidy, S. (2021). Gut
bacteria-derived 5-hydroxyindole is a potent stimulant of
intestinal motility via its action on L-type calcium
channels. PLOS BIOLOGY,
19(1), Article e3001070. https://doi.org/10.1371/journal.pbio.3001070
van
Kessel, S. P., Auvinen, P., Scheperjans, F., & El
Aidy, S. (2021). Gut bacterial tyrosine decarboxylase
associates with clinical variables in a longitudinal cohort study
of Parkinsons disease. NPJ Parkinson's
disease, 7(1), Article 115. https://doi.org/10.1038/s41531-021-00260-0
Bunt,
D. V., Minnaard, A. J., & El Aidy,
S. (2021). Potential Modulatory Microbiome Therapies
for Prevention or Treatment of Inflammatory Bowel Diseases.
Pharmaceuticals, 14(6), Article 506.
https://doi.org/10.3390/ph14060506
Aresti-Sanz,
J., Schwalbe, M., Pereira, R. R.,
Permentier, H., & El Aidy, S. (2021).
Stability of methylphenidate under various ph conditions in
the presence or absence of gut microbiota.
Pharmaceuticals, 14(8), Article 733.
https://doi.org/10.3390/ph14080733
Jansma,
J., & El Aidy, S. (2021).
Understanding the host-microbe interactions using metabolic
modeling. Microbiome, 9(1),
Article 16. https://doi.org/10.1186/s40168-020-00955-1
2020
Kiewiet,
M. B. G., Elderman, M. E., Aidy, S.
E., Burgerhof, J. G. M., Visser,
H., Vaughan, E. E., Faas, M. M., & de
Vos, P. (2021). Flexibility of Gut Microbiota in
Ageing Individuals during Dietary Fiber Long-Chain Inulin
Intake. Molecular Nutrition & Food
Research, Article e2000390. https://doi.org/10.1002/mnfr.202000390
Jansma,
J., Brinkman, F., van Hemert, S., & El Aidy,
S. (2021). Targeting the endocannabinoid system with
microbial interventions to improve gut integrity.
Progress in Neuro-Psychopharmacology and Biological
Psychiatry, 106, Article 110169. https://doi.org/10.1016/j.pnpbp.2020.110169
Morais,
L. H., Golubeva, A. V., Moloney, G. M., Moya-Pérez, A.,
Ventura-Silva, A. P., Arboleya, S., Bastiaanssen, T. F. S.,
O'Sullivan, O., Rea, K., Borre, Y., Scott, K. A., Patterson, E.,
Cherry, P., Stilling, R., Hoban, A. E., El Aidy, S.,
Sequeira, A. M., Beers, S., Moloney, R. D., ... Cryan, J. F.
(2020). Enduring Behavioral Effects Induced by Birth by
Caesarean Section in the Mouse. Current
Biology, 30(19), 3761-3774. https://doi.org/10.1016/j.cub.2020.07.044
van
Kessel, S. P., de Jong, H. R., Winkel, S. L., van
Leeuwen, S. S., Nelemans, S. A., Permentier,
H., Keshavarzian, A., & El Aidy, S. (2020).
Gut bacterial deamination of residual levodopa medication for
Parkinson's disease. BMC Biology,
18(1), Article 137. https://doi.org/10.1186/s12915-020-00876-3
Haarman,
B., El Aidy, S., van Hemert, S., Fu,
J., Festen, N., & Sommer, I. E.
C. (2020). The gut-brain axis in bipolar disorder
and schizophrenia – a target for precision
psychiatry?. Abstract from Digitaal NVVP
voorjaarscongres , Netherlands.
Haarman,
B., Ioannou, M., Borkent,
J., Doorduin, J., Fu, J., El
Aidy, S., & Sommer, I. E. C. (2020).
The impact of intestinal permeability and intestinal
microbiome on cerebral immunological activity and myelination in
bipolar disorder. Poster session presented at 22nd
Annual Conference of the International Society for Bipolar
Disorders.
Haarman,
B. C. M., Ioannou, M., Borkent,
J., Doorduin, J., Fu, J., El
Aidy, S., & Sommer, I. E. C. (2020).
The impact of intestinal permeability and intestinal
microbiome on cerebral immunological activity and myelination in
bipolar disorder. Bipolar Disorders,
22, 84-85.
2019
El
Aidy, S., Bolsius, Y. G., Raven,
F., & Havekes, R. (2020). A brief
period of sleep deprivation leads to subtle changes in mouse gut
microbiota. Journal of Sleep Research,
29(6), Article e12920. https://doi.org/10.1111/jsr.12920
Bugda
Gwilt, K., González, D. P., Olliffe, N., Oller,
H., Hoffing, R., Puzan, M., El Aidy, S., & Miller,
G. M. (2020). Actions of Trace Amines in the
Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1
(TAAR1). Cellular and molecular
neurobiology, 40(2), 191-201. https://doi.org/10.1007/s10571-019-00772-7
van
Kessel, S. P., & El Aidy, S. (2019).
Bacterial Metabolites Mirror Altered Gut Microbiota
Composition in Patients with Parkinson's Disease.
Journal of Parkinson's Disease,
9(2), S359-S370. https://doi.org/10.3233/JPD-191780
van
Kessel, S. P., & El Aidy, S. (2019).
Contributions of Gut Bacteria and Diet to Drug
Pharmacokinetics in the Treatment of Parkinson's Disease.
Frontiers in Neurology, 10, Article
1087. https://doi.org/10.3389/fneur.2019.01087
van
Kessel, S. P., Frye, A. K., El-Gendy, A. O., Castejon, M.,
Keshavarzian, A., van Dijk, G., & El Aidy,
S. (2019). Gut bacterial tyrosine decarboxylases
restrict levels of levodopa in the treatment of Parkinson's
disease. Nature Communications,
10(1), Article 310. https://doi.org/10.1038/s41467-019-08294-y
Aarts,
E., & El Aidy, S. (2019). Increasing
reproducibility and interpretability of microbiota-gut-brain
studies on human neurocognition and intermediary microbial
metabolites. Behavioral and Brain
Sciences, 42, Article e61. https://doi.org/10.1017/S0140525X18002777
Sanz,
J. A., & El Aidy, S. (2019).
Microbiota and gut neuropeptides: a dual action of
antimicrobial activity and neuroimmune response.
Psychopharmacology, 236(5),
1597-1609. https://doi.org/10.1007/s00213-019-05224-0
Torres-Fuentes,
C., Golubeva, A. V., Zhdanov, A. V., Wallace, S., Arboleya, S.,
Papkovsky, D. B., El Aidy, S., Ross, P., Roy, B. L.,
Stanton, C., Dinan, T. G., Cryan, J. F., & Schellekens, H.
(2019). Short-chain fatty acids and microbiota metabolites
attenuate ghrelin receptor signaling. The FASEB
Journal, 33(12), 13546-13559. https://doi.org/10.1096/fj.201901433R
2018
Waclawikova,
B., & El Aidy, S. (2018). Role of
Microbiota and Tryptophan Metabolites in the Remote Effect of
Intestinal Inflammation on Brain and Depression.
Pharmaceuticals, 11(3), Article 63.
https://doi.org/10.3390/ph11030063
Bears,
A., Oosting, A., Lohuis, M., Koehorse, M., El Aidy,
S., Hugenholtz, F., Smidt, H., Mischke, M., Boekschoten, M.
V., Verkade, H. J., Garssen, J., van der Beek,
E. M., Knol, J., de Vos, P., van
Bergenhenegouwen, J., & Fransen, F. (2018). Sex
differences in lipid metabolism are affected by presence of the gut
microbiota. Scientific Reports,
8, Article 13426. https://doi.org/10.1038/s41598-018-31695-w
2017
Fransen,
F., van Beek, A. A., Borghuis, T., El Aidy, S.,
Hugenholtz, F., van der Gaast-de Jongh, C., Savelkoul, H. F. J., De
Jonge, M. I., Boekschoten, M. V., Smidt, H., Faas, M.
M., & de Vos, P. (2017). Aged Gut
Microbiota Contributes to Systemical Inflammaging after Transfer to
Germ-Free Mice. Frontiers in
Immunology, 8, Article 1385. https://doi.org/10.3389/fimmu.2017.01385
Koopman,
M., El Aidy, S., & MIDtrauma Consortium (2017).
Depressed gut? The microbiota-diet-inflammation trialogue in
depression. Current opinion in
psychiatry, 30(5), 369-377. https://doi.org/10.1097/YCO.0000000000000350
El
Aidy, S., Ramsteijn, A. S., Dini-Andreote,
F., van Eijk, R., Houwing, D. J., Salles, J.
F., & Olivier, J. D. A. (2017).
Serotonin transporter genotype modulates the gut microbiota
composition in young rats, an effect augmented by early life
stress. Frontiers in cellular
neuroscience, 11, Article 222. https://doi.org/10.3389/fncel.2017.00222
Fransen,
F., van Beek, A. A., Borghuis, T., Meijer, B., Hugenholtz, F., van
der Gaast-de Jongh, C., Savelkoul, H. F., de Jonge, M. I.,
Faas, M. M., Boekschoten, M. V., Smidt, H., El Aidy,
S., & de Vos, P. (2017). The Impact
of Gut Microbiota on Gender-Specific Differences in
Immunity. Frontiers in Immunology,
8, Article 754. https://doi.org/10.3389/fimmu.2017.00754
Vinke,
P. C., El Aidy, S., & van Dijk,
G. (2017). The role of supplemental complex dietary
carbohydrates and gut microbiota in promoting cardiometabolic and
immunological health in obesity: Lessons from healthy non-obese
individuals. Frontiers in nutrition,
4, Article 34. https://doi.org/10.3389/fnut.2017.00034
Fransen,
F., Sahasrabudhe, N. M., Elderman, M., Bosveld,
M., El Aidy, S., Hugenholtz, F., Borghuis, T.,
Kousemaker, B., Winkel, S., Gaast-de Jongh, C. E., Jonge, M. I. D.,
Boekschoten, M. V., Smidt, H., Schols, H. A., & de Vos,
P. (2017). β2→ 1-fructans modulate the
immune system in vivo by direct interaction with the mucosa in a
microbiota-independent fashion. Frontiers in
Immunology, 8, Article 154. https://doi.org/10.3389/fimmu.2017.00154
2016
El
Aidy, S. (2016). De invloed op ons brein. In M.
Kleerebezem, W. Hoekstra, & A. van de Graaf (Eds.), Ons
microbioom: Wat betekenen bacteriën voor onze gezondheid?
(4 ed., Vol. 35, pp. 54-57). (Cahier Biowetenschappen en
Maatschappij). Stichting Biowetenschappen en Maatschappij. http://www.biomaatschappij.nl/wordpress/wp-content/uploads/2016/12/Ons-microbioom.pdf?utm_source=cahier&utm_medium=pdf%20button&utm_campaign=cahier%20download
El
Aidy, S., Stilling, R., Dinan, T. G., & Cryan, J. F.
(2016). Microbiome to Brain: Unravelling the Multidirectional
Axes of Communication. In M. Lyte (Ed.), Microbial
Endocrinology: Interkingdom Signalling in Infectious Diseases and
Health (2 ed., Vol. 874, pp. 301-336). (Advances in
Experimental Medicine and Biology; Vol. 874). Springer
International Publishing AG. https://doi.org/10.1007/978-3-319-20215-0_15
Sarker,
S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P.,
Charton, F., Bourdin, G., Mccallin, S., Ngom-bru, C., Neville, T.,
Akter, M., Huq, S., Qadri, F., Talukdar, K., Kassam, M., Delley,
M., Loiseau, C., Deng, Y., El Aidy, S., ...
Brüssow, H. (2016). Oral Phage Therapy of Acute
Bacterial Diarrhea With Two Coliphage Preparations: A Randomized
Trial in Children From Bangladesh.
EBioMedicine, 124-137. https://doi.org/10.1016/j.ebiom.2015.12.023
Kelly,
J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy,
S., Deane, J., Kennedy, P. J., Beers, S., Scott, K.,
Moloney, G., Hoban, A. E., Scott, L., Fitzgerald, P., Ross, P.,
Stanton, C., Clarke, G., Cryan, J. F., & Dinan, T. G. (2016).
Transferring the blues: Depression-associated gut microbiota
induces neurobehavioural changes in the rat.
Journal of Psychiatric Research, 82,
109-118. https://doi.org/10.1016/j.jpsychires.2016.07.019
2015
Fransen,
F., Zagato, E., Mazzini, E., Fosso, B., Manzari, C., El Aidy,
S., Chiavelli, A., D'Erchia, A. M., Sethi, M. K., Pabst, O.,
Marzano, M., Moretti, S., Romani, L., Penna, G., Pesole, G., &
Rescigno, M. (2015). BALB/c and C57BL/6 Mice Differ in
Polyreactive IgA Abundance, which Impacts the Generation of
Antigen-Specific IgA and Microbiota Diversity.
Immunity, 43(3), 527-540. https://doi.org/10.1016/j.immuni.2015.08.011
Pusceddu,
M. M., El Aidy, S., Crispie, F., O'Sullivan, O.,
Cotter, P., Stanton, C., Kelly, P., Cryan, J. F., & Dinan, T.
G. (2015). Correction: N-3 Polyunsaturated Fatty Acids
(PUFAs) Reverse the Impact of Early-Life Stress on the Gut
Microbiota. PLoS ONE, 10(10),
Article e0142228. https://doi.org/10.1371/journal.pone.0142228
El
Aidy, S., Dinan, T. G., & Cryan, J. F. (2015). Gut
Microbiota: The conductor in the Orchestra of immune-neuroendocrine
communication. Clinical Therapeutics,
37(5), 954-967. https://doi.org/10.1016/j.clinthera.2015.03.002
Menckeberg,
C. L., Hol, J., Simons-Oosterhuis, Y., Raatgeep, H. R. C., de
Ruiter, L. F., Lindenbergh-Kortleve, D. J., Korteland-van Male, A.
M., El Aidy, S., van Lierop, P. P. E., Kleerebezem,
M., Groeneweg, M., Kraal, G., Elink-Schuurman, B. E., de Jongste,
J. C., Nieuwenhuis, E. E. S., & Samsom, J. N. (2015).
Human buccal epithelium acquires microbial hyporesponsiveness
at birth, a role for secretory leukocyte protease inhibitor.
Gut, 64(6), 884-893. https://doi.org/10.1136/gutjnl-2013-306149
Pusceddu,
M. M., El Aidy, S., Crispie, F., O'Sullivan, O.,
Cotter, P., Stanton, C., Kelly, P., Cryan, J. F., & Dinan, T.
G. (2015). N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse
the Impact of Early-Life Stress on the Gut Microbiota.
PLoS ONE, 10(10), Article e0139721.
https://doi.org/10.1371/journal.pone.0139721
El
Aidy, S., van den Bogert, B., & Kleerebezem, M. (2015).
The small intestine microbiota, nutritional modulation and
relevance for health. Current Opinion in
Biotechnology, 32, 14-20. https://doi.org/10.1016/j.copbio.2014.09.005
2014
El
Aidy, S., Dinan, T. G., & Cryan, J. F. (2014).
Immune modulation of the brain-gut-microbe axis.
Frontiers in Microbiology, 5,
Article 146. https://doi.org/10.3389/fmicb.2014.00146
El
Aidy, S., Derrien, M., Aardema, R., Hooiveld, G., Richards,
S. E., Dane, A., Dekker, J., Vreeken, R., Levenez, F., Doré,
J., Zoetendal, E. G., van Baarlen, P., & Kleerebezem, M.
(2014). Transient inflammatory-like state and microbial
dysbiosis are pivotal in establishment of mucosal homeostasis
during colonisation of germ-free mice. Beneficial
microbes, 5(1), 67-77. https://doi.org/10.3920/BM2013.0018
2013
El
Aidy, S., Derrien, M., Merrifield, C. A., Levenez, F.,
Doré, J., Boekschoten, M. V., Dekker, J., Holmes, E.,
Zoetendal, E. G., van Baarlen, P., Claus, S. P., & Kleerebezem,
M. (2013). Gut bacteria-host metabolic interplay during
conventionalisation of the mouse germfree colon.
The ISME journal, 7(4), 743-755. https://doi.org/10.1038/ismej.2012.142
El
Aidy, S., Van den Abbeele, P., Van de Wiele, T., Louis, P.,
& Kleerebezem, M. (2013). Intestinal colonization: how
key microbial players become established in this dynamic process:
microbial metabolic activities and the interplay between the host
and microbes. BioEssays,
35(10), 913-923. https://doi.org/10.1002/bies.201300073
El
Aidy, S., & Kleerebezem, M. (2013). Molecular
signatures for the dynamic process of establishing intestinal
host-microbial homeostasis: potential for disease
diagnostics? Current opinion in
gastroenterology, 29(6), 621-627. https://doi.org/10.1097/MOG.0b013e328365d365
Van
den Abbeele, P., Verstraete, W., El Aidy, S.,
Geirnaert, A., & Van de Wiele, T. (2013). Prebiotics,
faecal transplants and microbial network units to stimulate
biodiversity of the human gut microbiome.
Microbial Biotechnology, 6(4),
335-340. https://doi.org/10.1111/1751-7915.12049
El
Aidy, S., Hooiveld, G., Tremaroli, V., Bäckhed, F.,
& Kleerebezem, M. (2013). The gut microbiota and mucosal
homeostasis: colonized at birth or at adulthood, does it
matter? Gut Microbes, 4(2),
118-124. https://doi.org/10.4161/gmic.23362
El
Aidy, S., Merrifield, C. A., Derrien, M., van Baarlen, P.,
Hooiveld, G., Levenez, F., Dore, J., Dekker, J., Holmes, E., Claus,
S. P., Reijngoud, D.-J., & Kleerebezem, M. (2013).
The gut microbiota elicits a profound metabolic reorientation
in the mouse jejunal mucosa during conventionalisation.
Gut, 62(9), 1306-1314. https://doi.org/10.1136/gutjnl-2011-301955
2012
El
Aidy, S., van Baarlen, P., Derrien, M.,
Lindenbergh-Kortleve, D. J., Hooiveld, G., Levenez, F., Dore, J.,
Dekker, J., Samsom, J. N., Nieuwenhuis, E. E. S., &
Kleerebezem, M. (2012). Temporal and spatial interplay of
microbiota and intestinal mucosa drive establishment of immune
homeostasis in conventionalized mice. Mucosal
immunology, 5(5), 567-579. https://doi.org/10.1038/mi.2012.32
El
Aidy, S., Kunze, W., Bienenstock, J., & Kleerebezem, M.
(2012). The microbiota and the gut-brain axis: insights from
the temporal and spatial mucosal alterations during colonisation of
the germfree mouse intestine. Beneficial
microbes, 3(4), 251-259. https://doi.org/10.3920/BM2012.0042
2011
Van
den Abbeele, P., Gérard, P., Rabot, S., Bruneau, A., El
Aidy, S., Derrien, M., Kleerebezem, M., Zoetendal, E. G.,
Smidt, H., Verstraete, W., Van de Wiele, T., & Possemiers, S.
(2011). Arabinoxylans and inulin differentially modulate the
mucosal and luminal gut microbiota and mucin-degradation in
humanized rats. Environmental
Microbiology, 13(10), 2667-2680. https://doi.org/10.1111/j.1462-2920.2011.02533.x
2010
Booijink,
C. C. G. M., El-Aidy, S.,
Rajilić-Stojanović, M., Heilig, H. G. H. J., Troost, F.
J., Smidt, H., Kleerebezem, M., De Vos, W. M., & Zoetendal, E.
G. (2010). High temporal and inter-individual variation
detected in the human ileal microbiota.
Environmental Microbiology, 12(12),
3213-3227. https://doi.org/10.1111/j.1462-2920.2010.02294.x
Van
den Abbeele, P., Grootaert, C., Marzorati, M., Possemiers, S.,
Verstraete, W., Gerard, P., Rabot, S., Bruneau, A., El Aidy,
S., Derrien, M., Zoetendal, E., Kleerebezem, M., Smidt, H.,
& Van de Wiele, T. (2010). Microbial Community
Development in a Dynamic Gut Model Is Reproducible, Colon Region
Specific, and Selective for Bacteroidetes and Clostridium Cluster
IX. Applied and environmental
microbiology, 76(15), 5237-5246. https://doi.org/10.1128/AEM.00759-10
Last modified: | 09 June 2023 8.36 p.m. |